• 1
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 1999; 341(23): 17251730.
  • 2
    Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58(3): 13111317.
  • 3
    Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74(10): 13771381.
  • 4
    Ojo AO, Hanson JA, Meier-Kriesche H et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12(3): 589597.
  • 5
    Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2(8): 701711.
  • 6
    Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74(9): 12811286.
  • 7
    Gaston RS, Danovitch GM, Adams PL et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003; 3(7): 775785.
  • 8
    Lee CM, Carter JT, Randall HB et al. The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts. J Surg Res 2000; 91(1): 8388.
  • 9
    Johnston TD, Thacker LR, Jeon H, Lucas BA, Ranjan D. Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004; 18 (Suppl 12): 2832.
  • 10
    Sung RS, Guidinger MK, Lake CD et al. Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation 2005; 79(9): 12571261.
  • 11
    Smits JM, Persijn GG, Van Houwelingen HC, Claas FH, Frei U. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002; 2(7): 664670.
  • 12
    Fritsche L, Horstrup J, Budde K et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant 2003; 3(11): 14341439.
  • 13
    Brenner BM, Milford EL. Nephron underdosing: A programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21(5 Suppl 2): 6672.
  • 14
    Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. Jama 1996; 276(21): 17321736.
  • 15
    Nicholson ML, Windmill DC, Horsburgh T, Harris KP. Influence of allograft size to recipient body-weight ratio on the long-term outcome of renal transplantation. Br J Surg 2000; 87(3): 314319.
  • 16
    Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7(8): 11061122.
  • 17
    Stratta RJ, Rohr MS, Sundberg AK et al. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg 2004; 239(5): 688695; discussion 95-7.
  • 18
    Delmonico FL, Wynn JJ. Managing the enlarging waiting list. Am J Transplant 2002; 2(10): 889890.
  • 19
    Schnitzler MA, Whiting JF, Brennan DC et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003; 75(12): 19401945.
  • 20
    Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 2001; 1 (Suppl 2): 395.
  • 21
    Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995; 60(4): 334339.
  • 22
    Pokorna E, Vitko S, Chadimova M, Schuck O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000; 69(1): 3643.
  • 23
    Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71(10): 13611365.
  • 24
    Bryan CF, Luger AM, Martinez J et al. Cold ischemia time: An independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation 2001; 71(7): 875879.
  • 25
    McTaggart RA, Gottlieb D, Brooks J et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3(4): 416423.
  • 26
    Smith KD, Wrenshall LE, Nicosia RF et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003; 14(4): 10371045.